Drug interactions
Brexucabtagene autoleucel + Mycophenolate mofetil
Severity: Major
Brexucabtagene autoleucel and Mycophenolate mofetil: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Mycophenolate can blunt CAR T-cell proliferation and so may reduce the efficacy of this therapy. It also increases infection risk in patients who are already immunocompromised.
What this interaction means in plain words
Brexucabtagene autoleucel and Mycophenolate mofetil can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Brexucabtagene autoleucel belongs to Oncology; Mycophenolate mofetil belongs to Miscellaneous.
Why it happens
Mycophenolate inhibits lymphocyte proliferation, potentially impairing CAR T-cell expansion, with additive immunosuppression.
What to do
Avoid mycophenolate around leukapheresis and infusion unless clinically necessary, coordinating with the CAR T team; monitor for infection and response.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Brexucabtagene autoleucel and Mycophenolate mofetil, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Mycophenolate mofetil
- Adenovirus types 4 and 7 live + Mycophenolate mofetil Contraindicated
- Bcg vaccine live + Mycophenolate mofetil Contraindicated
- Influenza virus vaccine quadrivalent intranasal + Mycophenolate mofetil Contraindicated
- Measles mumps and rubella vaccine live + Mycophenolate mofetil Contraindicated
- Measles mumps rubella and varicella vaccine live + Mycophenolate mofetil Contraindicated
- Measles vaccine + Mycophenolate mofetil Contraindicated
Other interactions of Brexucabtagene autoleucel
Frequently asked questions
Can I take Brexucabtagene autoleucel with Mycophenolate mofetil?
MediHelp rates the interaction as major. Brexucabtagene autoleucel and Mycophenolate mofetil can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Mycophenolate can blunt CAR T-cell proliferation and so may reduce the efficacy of this therapy. It also increases infection risk in patients who are already immunocompromised.
How serious is the interaction between Brexucabtagene autoleucel and Mycophenolate mofetil?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid mycophenolate around leukapheresis and infusion unless clinically necessary, coordinating with the CAR T team; monitor for infection and response.
What other medicines interact with Mycophenolate mofetil?
MediHelp also lists interactions of Mycophenolate mofetil with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal. The full list is on the Mycophenolate mofetil page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
